This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Blue Blood Biotech Corp.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Yi-Kai Hong: Innovator in Wound Healing Technologies
Introduction
Yi-Kai Hong is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of wound healing. His innovative work has the potential to improve the quality of care for patients with open wounds.
Latest Patents
Yi-Kai Hong holds a patent for a composition aimed at promoting wound healing. This pharmaceutical composition is designed to accelerate the closure of open wounds in subjects in need. The composition includes a therapeutically effective amount of a recombinant polypeptide that is at least 80% identical to the amino acid sequence of SEQ ID NO: 2, along with a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Hong is associated with Blue Blood Biotech Corp., where he applies his expertise in biotechnology to develop innovative solutions. His work at the company reflects his dedication to enhancing healthcare through scientific research and development.
Collaborations
Some of his notable coworkers include Guey-Yueh Shi and Kuan-Chieh Wang. Their collaboration contributes to the innovative environment at Blue Blood Biotech Corp., fostering advancements in biotechnology.
Conclusion
Yi-Kai Hong's contributions to wound healing technologies exemplify the impact of innovation in healthcare. His patent and work at Blue Blood Biotech Corp. demonstrate his commitment to improving patient outcomes through scientific advancements.